دورية أكاديمية
COX-2 Overexpression in Schneiderian Papillomas.
العنوان: | COX-2 Overexpression in Schneiderian Papillomas. |
---|---|
المؤلفون: | Suh JD; Department of Head and Neck Surgery, University of California, Los Angeles, California., Hur K; Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California.; Department of Otolaryngology-Head and Neck Surgery, Northwestern University, Chicago, Illinois., Ference EH; Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California., Lam DD; Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California., Fong A; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California., Correa AJ; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California., Wrobel B; Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California. |
المصدر: | Allergy & rhinology (Providence, R.I.) [Allergy Rhinol (Providence)] 2020 Dec 08; Vol. 11, pp. 2152656720973689. Date of Electronic Publication: 2020 Dec 08 (Print Publication: 2020). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101570968 Publication Model: eCollection Cited Medium: Print ISSN: 2152-6575 (Print) Linking ISSN: 21526567 NLM ISO Abbreviation: Allergy Rhinol (Providence) Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Publication: 2018-2022 : Thousand Oaks, CA : SAGE Publications Original Publication: Providence, RI : Oceanside Publications |
مستخلص: | Background: Schneiderian papillomas (SP) are aggressive sinonasal tumors that occasionally extend into areas that are surgically unresectable. Objective: evaluate the signifcance of cyclo-oxygenase-2 (COX-2) expression in SP. Methods: Immunohistochemistry for COX-2 was performed on SP samples and middle turbinates from chronic rhinosinusitis without nasal polyps controls obtained during surgical resection between 2009-2017. A positive stain was defined as having 10% or more cells exhibiting diffuse immunoreactivity. Comparisons were performed using Fisher Exact tests, t-tests, and ANOVA. Results: The study included 67 tumor samples and 9 controls from two academic institutions. The mean age of the SP group was 55.4 years and 53.2 years in the control group (p = 0.71). Thirty-nine (58.2%) SP patients had previous surgery compared to 1 (11.1%) in the control group (p = 0.01). The most common tumor attachment sites were the maxillary (47.8%) and ethmoid (25.4%) sinuses. Fifteen (22.4%) SP samples stained strongly positive for COX-2 and 24 (35.8%) stained weakly positive compared to no positive stains in the control group (p < 0.01). When stratified by COX-2 intensity, there were no statistically significant differences in gender, smoking history, history of previous sinus surgery, site of attachment, papilloma subtype, or future recurrence between SP samples. Conclusion: COX-2 was overexpressed in 58.2% of SP cases, and strongly positive in 22.4% of cases, compared to no positive staining among controls. No significant differences in COX-2 expression were observed between SP subtypes or recurrent tumors. Further studies are warranted to evaluate COX-2 as a possible therapeutic target in tumors that overexpress the enzyme. Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2020.) |
References: | Radiol Oncol. 2013 Mar;47(1):71-6. (PMID: 23450506) Clin Cancer Res. 2001 Apr;7(4):861-7. (PMID: 11309334) Otolaryngol Head Neck Surg. 1995 Nov;113(5):558-63. (PMID: 7478645) Am J Otolaryngol. 2013 Jan-Feb;34(1):22-30. (PMID: 22951321) Eur Arch Otorhinolaryngol. 2008 Aug;265(8):917-22. (PMID: 18231801) Am J Otolaryngol. 1993 Sep-Oct;14(5):332-8. (PMID: 8238761) Int Forum Allergy Rhinol. 2013 Dec;3(12):997-1000. (PMID: 24106179) Laryngoscope. 2016 Feb;126(2):322-8. (PMID: 26344930) Int Forum Allergy Rhinol. 2015 Aug;5(8):701-7. (PMID: 26077310) Eur Arch Otorhinolaryngol. 2017 Aug;274(8):2991-3000. (PMID: 28432463) Cancer Cell Int. 2015 Nov 05;15:106. (PMID: 26549987) Acta Otolaryngol. 2009 Nov;129(11):1242-9. (PMID: 19863319) Mol Med. 2012 Mar 30;18:244-9. (PMID: 22113496) Am J Rhinol Allergy. 2013 Jul-Aug;27(4):287-92. (PMID: 23883810) Laryngoscope. 1999 Jul;109(7 Pt 1):1137-41. (PMID: 10401857) J Cancer Res Clin Oncol. 2001 Jul;127(7):411-7. (PMID: 11469677) Ear Nose Throat J. 2015 Apr-May;94(4-5):146-8. (PMID: 25923270) Acta Otolaryngol. 2006 Feb;126(2):214-8. (PMID: 16428203) Hum Pathol. 2002 Jul;33(7):708-14. (PMID: 12196922) Mol Med. 2007 Mar-Apr;13(3-4):143-50. (PMID: 17592548) Am J Otolaryngol. 2012 Sep-Oct;33(5):585-9. (PMID: 22534023) Head Neck Pathol. 2008 Jun;2(2):49-59. (PMID: 20614323) N Engl J Med. 2000 Jun 29;342(26):1946-52. (PMID: 10874062) Laryngoscope. 1995 Feb;105(2):178-83. (PMID: 8544600) Chest. 2009 Sep;136(3):924-926. (PMID: 19736197) |
معلومات مُعتمدة: | UL1 TR001855 United States TR NCATS NIH HHS |
فهرسة مساهمة: | Keywords: COX-2; Schneiderian papilloma; cyclo-oxygenase; inverted papilloma; oncocytic papilloma; sinonasal tumor |
تواريخ الأحداث: | Date Created: 20201221 Latest Revision: 20220419 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC7731694 |
DOI: | 10.1177/2152656720973689 |
PMID: | 33343991 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2152-6575 |
---|---|
DOI: | 10.1177/2152656720973689 |